Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer

23 Dec 2013

Abstract excerpt

A small subset of cells with CD133 expression is thought to have increased chemoresistance and tumorigenicity, features of cancer stem cells (CSCs); the molecular mechanisms by which these properties arise remain unclear. We characterized CD133+ endometrial cancer cells based on microarray analyses of Ishikawa cells. Of the genes upregulated in CD133+ cells compared with CD133- cells, we noted several key factors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24366104
DOI: 10.3892/ijo.2013.2230

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of CD133+ cancer stem-like cells in endometrial cancerPMID 24366104Read ↗

New emerging roles of CD133 in cancer stem cell: Signaling pathway and miRNA regulationSemantic proximity Read ↗

Characteristics of Cancer Stem Cells and Their Potential Role in Endometrial CancerSemantic proximity Read ↗

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinomaSemantic proximity Read ↗

Transformation of Epithelial Ovarian Cancer Stemlike Cells into Mesenchymal Lineage via EMT Results in Cellular Heterogeneity and Supports Tumor EngraftmentSemantic proximity Read ↗

Preliminary identification of endometrial cancer stem cells in vitro and in vivoSemantic proximity Read ↗

CD133 as a Marker for Cancer Stem Cells: Progresses and ConcernsSemantic proximity Read ↗

Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).Semantic proximity Read ↗

CD133: A cancer stem cells marker, is used in colorectal cancersSemantic proximity Read ↗

A stemness-based signature with inspiring indications in discriminating the prognosis, immune response, and somatic mutation of endometrial cancer patients revealed by machine learning.Semantic proximity Read ↗

Investigating Molecular Profiles of Ovarian Cancer: An Update on Cancer Stem CellsSemantic proximity Read ↗

Identification and characterization of CD133+CD44+ cancer stem cells from human laryngeal squamous cell carcinoma cell linesSemantic proximity Read ↗

A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.